BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30016542)

  • 21. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
    Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
    Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression of 17beta-estradiol-metabolizing isozymes: comparison of normal human mammary gland to normal human liver and to cultured human breast adenocarcinoma cells.
    Lehmann L; Wagner J
    Adv Exp Med Biol; 2008; 617():617-24. PubMed ID: 18497089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
    Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.
    Dani M; Boisvert C; Michaud J; Naud J; Lefrançois S; Leblond FA; Pichette V
    Drug Metab Dispos; 2010 Mar; 38(3):357-60. PubMed ID: 20007296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Lee JT; Pao LH; Hsiong CH; Huang PW; Shih TY; Yoa-Pu Hu O
    Talanta; 2013 Mar; 106():220-8. PubMed ID: 23598120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis.
    Vasilogianni AM; Al-Majdoub ZM; Achour B; Annie Peters S; Barber J; Rostami-Hodjegan A
    Clin Pharmacol Ther; 2022 Sep; 112(3):699-710. PubMed ID: 35510337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles of drug-metabolizing enzymes and transporters with an overexpression of hepatocyte growth factor.
    Kakizaki S; Yamazaki Y; Kosone T; Horiguchi N; Sohara N; Sato K; Takagi H; Yoshinari K; Mori M
    Liver Int; 2007 Feb; 27(1):109-19. PubMed ID: 17241389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1.
    Lu D; Ma Z; Zhang T; Zhang X; Wu B
    Xenobiotica; 2016; 46(1):1-13. PubMed ID: 26068521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.
    Kennon-McGill S; Clemens MM; McGill MR
    Hear Res; 2019 Aug; 379():98-102. PubMed ID: 31121337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.
    Shi R; Wu J; Meng C; Ma B; Wang T; Li Y; Ma Y
    Biopharm Drug Dispos; 2016 Oct; 37(7):433-443. PubMed ID: 27514509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Nrf2 knockout on the constitutive expression of drug metabolizing enzymes and transporters in C57Bl/6 mice livers.
    Anwar-Mohamed A; Degenhardt OS; El Gendy MA; Seubert JM; Kleeberger SR; El-Kadi AO
    Toxicol In Vitro; 2011 Jun; 25(4):785-95. PubMed ID: 21281708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of
    Althaher AR; Jarrar Y; Al-Ibadah MA; Balasmeh R; Jarrar Q; Abulebdah D
    Microrna; 2024; 13(1):63-70. PubMed ID: 38265404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.
    Ghose R; Omoluabi O; Gandhi A; Shah P; Strohacker K; Carpenter KC; McFarlin B; Guo T
    Life Sci; 2011 Jul; 89(1-2):57-64. PubMed ID: 21620874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of pharmacokinetics of chrysin and its conjugates in wild-type FVB and Bcrp1 knockout mice using a validated LC-MS/MS method.
    Ge S; Gao S; Yin T; Hu M
    J Agric Food Chem; 2015 Mar; 63(11):2902-10. PubMed ID: 25715997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes.
    Shi X; Zhang G; Mackie B; Yang S; Wang J; Shan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():145-156. PubMed ID: 27428458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice.
    Wang P; Shao X; Bao Y; Zhu J; Chen L; Zhang L; Ma X; Zhong XB
    Acta Pharm Sin B; 2020 Jan; 10(1):171-185. PubMed ID: 31993314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats.
    Kawase A; Ito A; Yamada A; Iwaki M
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):239-44. PubMed ID: 24899460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver.
    Kato K; Ohbuchi M; Hamamura S; Ohshita H; Kazuki Y; Oshimura M; Sato K; Nakada N; Kawamura A; Usui T; Kamimura H; Tateno C
    Drug Metab Dispos; 2015 Aug; 43(8):1208-17. PubMed ID: 25979261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.